首页> 外文期刊>Bone marrow transplantation >Post-allograft pomalidomide and reversible hepatotoxicity.
【24h】

Post-allograft pomalidomide and reversible hepatotoxicity.

机译:同种异体移植后的pomalidomide和可逆性肝毒性。

获取原文
获取原文并翻译 | 示例
           

摘要

Using a comprehensive microarray database of human gene expression, we identified that in mammals, a secreted protein known as isthmin 1 (ISM1) is expressed in skin, mucosal tissues, and selected lymphocyte populations. ISM1 was originally identified in Xenopus brain during development, and it encodes a predicted ~50-kDa protein containing a signal peptide, a thrombospondin domain, and an adhesion-associated domain. We confirmed the pattern of expression of ISM1 in both human and mouse tissues. ISM1 is expressed by DX5(+) lung lymphocytes that include NK and NKT-like cells, and is also expressed by some CD4(+) T cells upon activation but its expression increases significantly when CD4(+) T cells were polarized to the Th17 lineage in vitro. The presence of IFN-γ during CD4(+) T cell polarization inhibits ISM1 expression. Given that ISM1 has been reported to have anti-angiogenic properties, these observations suggest that ISM1 is a mediator of lymphocyte effector functions and may participate in both innate and acquired immune responses.
机译:使用人类基因表达的综合微阵列数据库,我们确定了在哺乳动物中,称为isthmin 1(ISM1)的分泌蛋白在皮肤,粘膜组织和选定的淋巴细胞群体中表达。 ISM1最初在非洲爪蟾的大脑发育过程中被鉴定出来,它编码一个预测的〜50 kDa的蛋白质,该蛋白质包含一个信号肽,一个血小板反应蛋白结构域和一个粘附相关结构域。我们证实了人和小鼠组织中ISM1的表达模式。 ISM1由包括NK和NKT样细胞的DX5(+)肺淋巴细胞表达,并且在激活后也由某些CD4(+)T细胞表达,但是当CD4(+)T细胞极化到Th17时,其表达显着增加。体外血统。 CD4(+)T细胞极化期间IFN-γ的存在抑制ISM1表达。考虑到已报道ISM1具有抗血管生成特性,这些观察结果表明ISM1是淋巴细胞效应子功能的介体,并且可能参与先天和后天免疫应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号